Wilmington R&D Tax Credit Explained for Businesses

R&D Tax Credits for Wilmington, Delaware Businesses

Wilmington, Delaware, is a hub for industries such as finance, healthcare, education, and chemical manufacturing. Top companies in the city include JPMorgan Chase, a leading financial services provider; ChristianaCare, a major healthcare provider; the University of Delaware, a key educational institution; DuPont, a prominent chemical manufacturing company; and Bank of America, a major financial services provider. The Research and Development (R&D) Tax Credit can help these industries reduce their tax liabilities, foster innovation, and enhance business performance.

Find out more

Are you eligible?

Why choose us?

Pass an Audit?

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed’s office location at 3616 Kirkwood Hwy, Wilmington, Delaware provides R&D tax credit consulting and advisory services to Wilmington and the surrounding areas such as: Dover, Newark, Middletown, Bear and Glasgow.

If you have any questions or need further assistance, please call or email our local Delaware Partner on (302) 342-0410.
Feel free to book a quick teleconference with one of our Delaware R&D tax credit specialists at a time that is convenient for you. Click here for more information about R&D tax credit management and implementation.

Schedule a Teleconference

Wilmington, Delaware Patent of the Year – 2024/2025

Valcare Medical Inc. has been awarded the 2024/2025 Patent of the Year for advancing minimally invasive heart valve repair. Their invention, detailed in U.S. Patent No. 12115069, titled ‘Percutaneous annuloplasty system with anterior-posterior adjustment’, uses a specially designed delivery system to improve placement and anchoring of mitral valve implants.

This new system simplifies how doctors treat mitral valve regurgitation, a condition where the heart valve fails to close properly, leading to blood leakage. The patented technology allows for more accurate and secure implantation of an artificial valve while minimizing damage to nearby tissues. It uses a steerable shaft and expandable anchor system that can adapt to a patient’s unique heart structure.

The innovation supports faster, safer procedures and shorter recovery times compared to open-heart surgery. It also addresses long-standing challenges in aligning and stabilizing implants inside a constantly moving heart. With this device, physicians gain better control during complex procedures, improving outcomes for patients with high surgical risks.

Valcare Medical Inc. specializes in structural heart innovations, and this patent reflects its focus on practical tools that meet real clinical needs. As the global demand for less invasive heart treatments grows, this technology offers a path toward more accessible, life-saving care for millions with heart valve disease.